Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
Delayed Quote. Delayed Nyse - 09/20 04:10:00 pm
44.2 USD   +0.71%
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
DJ
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -2-
DJ
06:04aNORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Israel delivers booster shots of vaccine to people over 60

07/30/2021 | 06:29am EDT

JERUSALEM (AP) — Israeli health authorities began administering coronavirus booster shots Friday to people over 60 who've already received both does of a vaccine, in a bid to combat a recent spike in cases.

The decision was announced Thursday by the Israeli prime minister, Naftali Bennet, making Israel the first country to offer a third dose of a Western vaccine to its citizens on a wide scale.

″Israel is a pioneer in going ahead with the third dose for older people of the age of 60 and above,″ Bennet said during Friday's launch.

The decision comes following rising infections caused by the delta variant, and indications that the vaccine’s efficacy drops over time.

Bennett said that a team of expert advisers had overwhelmingly agreed that the booster campaign was necessary. He said that this decision was made after “considerable research and analysis” and that its information would be shared around the world.

″The only way we can defeat COVID is together. Together means sharing information. Together means sharing methods, technologies, insights, and actionable steps,″ said Bennet said Friday.

More than 57% of the country’s 9.3 million citizens have received both doses of the Pfizer/BioNTech vaccine, and over 80% of the population over 40 is vaccinated.

Neither the U.S. nor the EU has approved coronavirus booster shots, and the World Health Organization said earlier this month that there is not enough evidence to show that a third dose is needed.

Most studies — and real-world data from Britain and the U.S. — so far show that the Pfizer vaccine remains powerfully protective against serious illness. Just Wednesday, Pfizer released data from its long-running 44,000-person study showing that while protection against any symptomatic infection declined slightly six months after immunization, protection against severe COVID-19 remained at nearly 97%. Earlier this month, Israel’s Health Ministry announced that protection against severe disease was around 93%.

Israel has carried out one of the world’s quickest and most successful vaccination campaigns. They reached a deal with the pharmaceutical company, Pfizer, to purchase enough vaccines for its population in exchange for sharing its data with the drugmaker.

The vaccination program allowed Israel to reopen its economy before other countries. The Israeli government had planned to reopen the country to vaccinated tourists in July but has pushed the date back following concerns over the rise in cases.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about PFIZER, INC.
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
DJ
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -2-
DJ
06:04aNORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
DJ
04:00aPFIZER : Thai campaign to vaccinate schoolchildren makes progress
AQ
03:12aMARKETMIND : Losing the plot
RE
09/20PFIZER : vaccine found to be safe, effective for children aged 5-11
AQ
09/20PFIZER : announces its vaccine is effective for kids 5-11
AQ
09/20Healthcare Shares Fall Amid Concerns About Delta Variant -- Healthcare Roundup
DJ
09/20Chevron, D.R. Horton fall; Pfizer, Brooks Automation rise
AQ
09/20MODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 111 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,1x
Yield 2021 3,57%
Capitalization 248 B 248 B -
EV / Sales 2021 3,41x
EV / Sales 2022 4,03x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 44,20 $
Average target price 45,08 $
Spread / Average Target 1,99%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.19.23%247 816
JOHNSON & JOHNSON4.09%431 227
ROCHE HOLDING AG10.52%321 941
NOVO NORDISK A/S48.69%229 255
ELI LILLY AND COMPANY37.20%210 000
ABBVIE INC.-0.70%188 027